Key result
Pre-existing coagulopathies in patients undergoing open-heart surgeries with cardiopulmonary bypass can cause serious complications if not recognized and appropriately managed with tailored strategies.
Why the study?
What are the risks and management strategies for patients with pre-existing coagulopathies undergoing cardiac surgery with cardiopulmonary bypass?
What are the risks and management strategies for patients with pre-existing coagulopathies undergoing cardiac surgery with cardiopulmonary bypass?
Proper diagnosis and management of pre-existing coagulopathy disorders, including routine coagulation work-up, is crucial for patients undergoing cardiac procedures with cardiopulmonary bypass to prevent serious bleeding complications.
Patients with pre-existing coagulopathies who undergo surgical interventions are at increased risk for bleeding complications. This risk is especially true in cardiac surgical procedures with cardiopulmonary bypass (CPB) because of the necessity for heparinization and the use of the extracorporeal circuits, which have destructive effects on most of the blood components. In this review, cases of cardiac surgeries in patients with certain pre-existing coagulopathies are summarized, which could shed a light on future managements of such patients undergoing cardiac procedures with CPB. Pre-existing coagulopathies include antithrombin III deficiency, heparin-induced thrombocytopenia, cancer, factor XII deficiency, hemophilia, idiopathic thrombocytopenic purpura, protein S deficiency, and drug-induced platelet inhibition. In summary, pre-existing coagulopathy in patients undergoing open-heart surgeries, if not recognized and appropriately managed, can cause serious complications. Management of patients undergoing cardiac procedures should include a routine coagulation work-up and a thorough past medical history examination. If any of the foregoing is abnormal, further evaluation is warranted. Proper diagnosis and management of the pre-existing coagulopathy disorders is of crucial importance to the surgical outcome and long-term morbidity.
No takes yet. Share an insight, caveat, or question.
DeBois et al. (2005) conducted a review in Pre-existing coagulopathy. Cardiopulmonary bypass management strategies was evaluated. Pre-existing coagulopathies in patients undergoing open-heart surgeries with cardiopulmonary bypass can cause serious complications if not recognized and appropriately managed with tailored strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: